Company-wide revenue
Reported revenue in 2021 ¥2.23T Reported revenue in 2025 ¥2.49T
- growth amount
- +¥253.87B
- growth annualized
- +2.7%
- growth total
- +11.4%
Japanese company profile · 9987
SUZUKEN CO.,LTD.
In its FY2025 public filing, SUZUKEN CO.,LTD. reports Pharmaceutical Wholesale Business, Healthcare product development, Regional health care support scheme, Specialty Pharmaceutical Distribution Trust, and 1 other reported businesses. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: 株式会社スズケン
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
SUZUKEN CO.,LTD.'s largest reported business by revenue in FY2025 was Pharmaceutical Wholesale Business.
The business with the highest reported segment profit in FY2025 was Pharmaceutical Wholesale Business.
FY2025 · fiscal year ended March 2026 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Pharmaceutical Wholesale Business | ¥2.4T ↗ | 96.6% | ¥31.47B ↗ |
| Specialty Pharmaceutical Distribution Trust | ¥436.1B ↗ | 17.5% | ¥1.16B ↗ |
| Regional health care support scheme | ¥93.94B ↗ | 3.8% | ¥1.55B ↗ |
| Healthcare product development | ¥51.64B ↗ | 2.1% | ¥830M ↗ |
| Healthcare related services | ¥42.96B ↗ | 1.7% | ¥1.28B ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Pharmaceutical Wholesale Business
- 医薬品卸売事業
- Healthcare product development
- ヘルスケア製品開発事業
- Regional health care support scheme
- 地域医療介護支援事業
- Specialty Pharmaceutical Distribution Trust
- スペシャリティ医薬品流通受託事業
- Healthcare related services
- 医療関連サービス等事業
- Business label unavailable in English
- 医薬品製造事業
- Insurance pharmacy business
- 保険薬局事業
- Sales
- 売上高
- Operating profit
- 営業利益
Original Japanese label
- Pharmaceutical Wholesale Business
- 医薬品卸売事業
- Healthcare product development
- ヘルスケア製品開発事業
- Regional health care support scheme
- 地域医療介護支援事業
- Specialty Pharmaceutical Distribution Trust
- スペシャリティ医薬品流通受託事業
- Healthcare related services
- 医療関連サービス等事業
- Business label unavailable in English
- 医薬品製造事業
- Insurance pharmacy business
- 保険薬局事業
- Sales
- 売上高
- Operating profit
- 営業利益
What is growing?
What is growing?
Business revenue growth
Pharmaceutical Wholesale Business
Reported revenue in 2021 ¥2.14T Reported revenue in 2025 ¥2.4T
- growth amount
- +¥256.68B
- growth annualized
- +2.9%
- growth total
- +12.0%
View original filing
Healthcare related services
Reported profit margin in 2022 +0.9%
Reported profit margin in 2025 +3.0%
- growth margin points
- +2.1
View original filing
Pharmaceutical Wholesale Business
Reported profit margin in 2022 +1.2%
Reported profit margin in 2025 +1.3%
- growth margin points
- +0.1
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2025 · fiscal year ended March 2026
The source document may be in Japanese.
Filing ID: S100YFRU
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.